Project profile — Global Drug Facility: Provision of Anti-Tuberculosis Drugs

Download project profile:

Overview

Overview

Global Drug Facility: Provision of Anti-Tuberculosis Drugs - Overview
CA-3-M011474003
$37,121,095
United Nations Office for ProjectServices: Stop TB Partnership (41502)
2010-03-20 - 2020-02-11
Closed
Country / region • Europe, regional (3.00%)
• Africa, regional (35.00%)
• America, regional (1.00%)
• Asia, regional (61.00%)
Sector • Basic Health
Tuberculosis control (12263) (100.00%)
Policy marker • Reproductive, Maternal, Newborn and Child Health (RMNCH) (explicit primary objective)
Description and results

Description

This grant represents part of Canada’s contribution to the Global Drug Facility (GDF), a program of the Stop TB Partnership. It provides access to anti-tuberculosis (TB) drugs for governments that agree to introduce, expand, or maintain the diagnostic, treatment, and monitoring policies of the DOTS (directly observed treatment, short-term) strategy. Launched in 2001, the GDF works to improve the supply, distribution, and monitoring of anti-TB drugs in developing countries and is the only global bulk procurer of anti-TB drugs. Canada was the founding donor of the GDF and to date (2010) has been the single largest donor country for first-line TB drugs. The GDF is a four-pronged mechanism whereby: (1) countries who cannot afford to procure all the anti-TB drug they need are eligible to apply for drugs for up to six years (DFATD provides funding for this component); (2) countries who can pay for the anti-TB drugs they need but cannot assure the quality of the drugs can directly procure them through the GDF at reduced bulk prices (DFATD funding does not contribute to this component); (3) countries where the procurement system is weak can receive technical assistance to strengthen their capacity for drug procurement (DFATD supports this component); and (4) Global Fund recipient countries can procure anti-TB drugs directly through GDF, using Global Fund monies, to ensure a stable and high-quality drug supply.

Results achieved

Results achieved by Global Drug Facility, through the support of the Government of Canada and other international donors, as of March 2016 include: (1) provided quality-assured treatments since 2001 for more than 27 million patients with tuberculosis (TB), This included over 184,000 patient treatments for multi-drug resistant TB (MDR-TB) and 1.5 million treatments for children; (2) delivered over 1.5 million patient treatments, including over 219,000 pediatric treatments in 2015; (3) provided capacity-building support to 134 countries since 2001, including training and workshops, monitoring missions and technical assistance to improve the management of drug supplies; (4) contributed to planning and guidance for the global introduction of new child-friendly medicines for pediatric TB; and (5) provided a mechanism for countries to order the new pediatric formulations and made grants available to eligible countries to purchase pediatric TB medicines with funding from Global Affairs Canada.

Financials

Financials


Original budget $0
Planned Disbursement $0
Transactions
Country Percentages by Sector
Related information

Related information

Global Drug Facility: Provision of Anti-Tuberculosis Drugs - Related information
Related links
Partner website — United Nations Office for ProjectServices: Stop TB Partnership
Global Affairs Canada
MFM Global Issues & Dev.Branch
Aid grant excluding debt reorganisation
Bilateral
Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO)
Legend

The coloured circles represent the number of markers in proximity. Simply click on the circle to zoom in for more information on projects.

2 to 9 markers 10 to 99 markers 100 to 999 markers 1,000 to 9,999 markers
Marker


Note: The Project Browser provides access to project data published by Global Affairs Canada in accordance with the International Aid Transparency Initiative (IATI) standard. This is not meant for official reporting, but to provide information on past and current international projects.

Date modified: